Start Date
August 31, 2003
Study Completion Date
July 31, 2007
bevacizumab
fluorouracil
leucovorin calcium
New York Weill Cornell Cancer Center at Cornell University, New York
Abramson Cancer Center of the University of Pennsylvania, Philadelphia
Lombardi Cancer Center, Washington D.C.
Duke Comprehensive Cancer Center, Durham
Saint Joseph Mercy Health System, Ann Arbor
St. Mary's/Duluth Clinic Cancer Center, Duluth
Sioux Valley Clinics - Oncology, Sioux Falls
Meritcare Roger Maris Cancer Center, Fargo
CCOP - Montana Cancer Consortium, Billings
Loyola University Medical Center, Maywood
Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago
University of Oklahoma Health Sciences Center, Oklahoma City
University of Colorado Cancer Center at University of Colorado Health Sciences Center, Aurora
Southern Nevada Cancer Research Foundation, Las Vegas
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles
CCOP - Virginia Mason Research Center, Seattle
Seattle Cancer Care Alliance, Seattle
Providence Alaska Medical Center, Anchorage
USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles
Yale Comprehensive Cancer Center, New Haven
CCOP - Atlanta Regional, Atlanta
Holden Comprehensive Cancer Center, Iowa City
Siouxland Hematology-Oncology, Sioux City
CCOP - Wichita, Wichita
Cancer Care of Maine, Bangor
University of Mississippi Medical Center, Jackson
Norris Cotton Cancer Center, Lebanon
Roswell Park Cancer Institute, Buffalo
Comprehensive Cancer Center at Wake Forest University, Winston-Salem
Ireland Cancer Center, Cleveland
Kimmel Cancer Center of Thomas Jefferson University - Philadelphia, Philadelphia
Fletcher Allen Health Care - University Health Center Campus, Burlington
Massey Cancer Center, Richmond
National Cancer Institute (NCI)
NIH